Personalis (PSNL) Cash from Investing Activities (2018 - 2026)
Personalis (PSNL) posted quarterly Cash from Investing Activities of -$46.0 million for Q1 2026, down 104.12% year-over-year from $1.1 billion in Q1 2025, and down 219.99% on a QoQ basis from -$14.4 million in Q4 2025.
Personalis (PSNL) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Personalis (PSNL) has reported Cash from Investing Activities for 9 consecutive years, with -$46.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 104.12% year-over-year to -$46.0 million; the TTM figure through Mar 2026 stood at -$46.0 million (up 27.97% YoY), while the FY2025 annual figure was -$22.6 million, up 35.65% from the prior year.
- Cash from Investing Activities came in at -$46.0 million for Q1 2026 at Personalis, down from -$14.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $23.0 million in Q2 2022, with the low at -$46.0 million in Q1 2026.
- Average Cash from Investing Activities over 5 years is -$2.2 million, with a median of -$3.2 million recorded in 2022.
- Across the five-year window, Cash from Investing Activities soared 536.35% in 2023 and plunged 457.75% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $21.9 million in 2022, then tumbled by 153.26% to -$11.6 million in 2023, then sank by 124.98% to -$26.2 million in 2024, then surged by 45.08% to -$14.4 million in 2025, then tumbled by 219.99% to -$46.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$46.0 million, -$14.4 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Personalis | 1.44 Bn | 1.20 Bn | 281,000.00 | -46.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.01 Mn |
| Mar 31, 2026 | -46.01 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Dec 31, 2025 | -14.38 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Jun 30, 2025 | -4.37 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Mar 31, 2025 | -22.54 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Sep 30, 2024 | -28.18 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Jun 30, 2024 | 12.99 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | -11.64 Mn |
| Dec 31, 2023 | -11.64 Mn |